Limitation is examined and approve, keep within limits is low-level repeat construction
In a paragraph of period, animal drug produces enterprise and good and evil people mixed up of animal drug product, the existence aggravate of enterprise of a large number of diminutive, non-standard animal drug preparation the market competes, make price war greatly, go against industry whole quality rise. Repeat construction to be reflected on one hand in pharmaceutical factory home overmuch, reflect on the other hand in breed repeat a newspaper to approve, repeat production to go up, major drug breed has enterprise of very much home, consummate a hunderd schools to produce. How the keep within limits, job key that eliminating serious repetition to build a phenomenon is trade superintendency department, also be policy directs. The country increased the examination of new animal drug and administrative strength, made clear what animal drug registers to handle affairs program and examine and approve time limit, the manufacturing attributive of new animal drug and animal drug product closes put in management of Ministry of Agriculture 's charge, deadline clears and standard of place of revocatory animal drug. With GMP guide and carry out raise business of animal drug pharmacy to enter " doorsill " , had limitted the pharmacy business amount of rapid growth. Animal drug company must pass GMP attestation. This action basically is examined and approve to animal drug and animal drug production has a standard.
　　 Normative standard, carry out GMP compulsively
Pharmacy business carries out GMP management is the practice with current international, our country carries out animal drug to produce enterprise GMP is one kind when conform with international is reflected, because the demand to capital, management is higher, drug of our country animal produces an enterprise to pass GMP attestation still amount to is not much. Pass GMP attestation, although from short-term look can increase company capital investment, increase operation cost, but can achieve in the long run assure quality of medicines and chemical reagents, eliminate the effect of lagging industry, be helpful for industry development. In fact, because pass GMP attestation place to require capital amount bigger, had caused a share business of pharmacy of small-sized animal drug is afterwards hard, had entered stop production or by the destiny of annex.
　　 The challenge that animal drug company faces
The development of new drug on international is a lengthy process, it is to discover to apply for to register patent on the molecular wheeler that has pharmacodynamics effect commonly, can be in inside a year exotic nation patent application, exceed a year of exotic nation to be accepted no longer. From register patent to appear on the market to need commonly to new drug 10 to 12 years. Current, the way that makes much abroad medicines and chemical reagents already passed the joint-stock, solely invested production that build a plant enters our country market in great quantities, if do obeisance to ear, brightness luck, general strong etc. Joint-stock animal drug, entrance animal drug held the market share that comparative on Chinese market. Because foreign pharmacy manufacturer makes cost tall, without price advantage, although have company of foreign animal drug,enter home market accordingly, but dozen do not win price war and still step forward dimension difficult. But, we must see go up in market of domestic animal drug, will present the situation that begs for be more than for years, domestic animal drug produces the gain that the enterprise scores to become as a result of bitter competition extremely scanty, lack the technology of research and development of new animal drug, management and capital dominant position badly, pressure has been shown very outstandingly.
上一页 1 23 4 下一页

上一篇：Courtyard of Chinese farming division 2007 working report
下一篇：Microbial additive reachs development foreground in the applied current situatio